本文選題：支氣管哮喘 + Th2免疫應(yīng)答�。� 參考：《上海交通大學(xué)》2015年博士論文

【摘要】：背景支氣管哮喘是以Th2免疫應(yīng)答為主的慢性過敏性氣道炎癥。近年研究發(fā)現(xiàn)嗜堿性粒細(xì)胞在不同疾病模型中能夠誘發(fā)Th2免疫應(yīng)答,但其具體機(jī)制目前尚不清楚。OX40-OX40L共刺激通路在Th細(xì)胞分化及哮喘中均發(fā)揮重要作用。目的通過體內(nèi)外研究闡釋并明確嗜堿性粒細(xì)胞始動(dòng)過敏性氣道炎癥的作用,在此基礎(chǔ)上進(jìn)一步探討嗜堿性粒細(xì)胞啟動(dòng)Th2免疫反應(yīng)誘發(fā)過敏性氣道炎癥的信號(hào)分子機(jī)制。方法1.利用OVA免疫小鼠建立哮喘氣道炎癥模型,觀察在哮喘炎癥早期小鼠縱隔淋巴結(jié)(Mediastinal lymph nodes,MLN)中嗜堿性粒細(xì)胞、樹突狀細(xì)胞(Dendritic cells,DCs)和Th2細(xì)胞的時(shí)間變化曲線和嗜堿性粒細(xì)胞表面分子表達(dá)的變化。2.建立IL-3誘導(dǎo)小鼠骨髓細(xì)胞定向分化為嗜堿性粒細(xì)胞的體外培養(yǎng)體系;流式細(xì)胞儀分選嗜堿性粒細(xì)胞并鑒定。在此基礎(chǔ)上觀察髓源性嗜堿性粒細(xì)胞(Bone marrow-derived basophils,BM-Bas)OX40和OX40L表達(dá)特點(diǎn)。3.建立體外嗜堿性粒細(xì)胞誘導(dǎo)Th2細(xì)胞分化體系,在此基礎(chǔ)上采用OX40L封閉性抗體(抗小鼠CD252抗體)或者OX40~-/- 小鼠na?ve T細(xì)胞,觀察在OX40-OX40L共刺激通路阻斷條件下對(duì)嗜堿性粒細(xì)胞誘導(dǎo)Th2細(xì)胞分化的影響。4.利用OVA致敏、激發(fā)C57BL/6小鼠構(gòu)建哮喘模型,在此基礎(chǔ)上在致敏階段尾靜脈注射OX40L阻斷性抗體(抗小鼠CD252抗體),觀察氣道病理組織學(xué)改變、血清OVA特異性Ig E(Ovalbumin-special immunoglobulin E,OVA-s Ig E)、支氣管肺泡灌洗液(Bronchial alveolar lavage fluid,BALF)中嗜酸性粒細(xì)胞數(shù)量和BALF中Th2型細(xì)胞因子IL-4、IL-5和IL-13的變化。5.建立體外過繼性回輸MLN嗜堿性粒細(xì)胞誘發(fā)小鼠哮喘模型,觀察阻斷OX40-OX40L共刺激通路后受體小鼠MLN Th2細(xì)胞比例變化及氣道病理組織學(xué)、血清OVA-s Ig E、BALF中嗜酸性粒細(xì)胞數(shù)量和Th2型細(xì)胞因子IL-4、IL-5和IL-13的變化。結(jié)果1.在哮喘炎癥早期,MLN中嗜堿性粒細(xì)胞數(shù)目顯著增加,而DCs無明顯變化,并且嗜堿性粒細(xì)胞數(shù)達(dá)到峰值時(shí)間早于Th2細(xì)胞。同時(shí)嗜堿性粒細(xì)胞表面OX40L信號(hào)分子變化最為顯著。2.體外IL-3誘導(dǎo)BM-Bas并受DNP-OVA和抗DNP-Ig E復(fù)合物刺激后誘導(dǎo)性表達(dá)OX40L。3.體外阻斷OX40-OX40L共刺激通路減少嗜堿性粒細(xì)胞誘導(dǎo)Th2細(xì)胞分化比例。4.致敏階段抗小鼠CD252抗體阻斷OX40-OX40L共刺激通路降低哮喘小鼠血清OVA-s Ig E、減少BALF中嗜酸性粒細(xì)胞數(shù)量、降低BALF中IL-4、IL5和IL-13水平,減輕肺組織過敏性氣道炎癥。5.體外過繼性回輸MLN嗜堿性粒細(xì)胞啟動(dòng)Th2免疫應(yīng)答誘發(fā)小鼠哮喘炎癥,而OX40~-/- 受體小鼠和回輸OX40L處理的嗜堿性粒細(xì)胞的WT C57BL/6受體小鼠MLN中Th2細(xì)胞比例降低,肺部過敏性氣道炎癥減輕。結(jié)論1.嗜堿性粒細(xì)胞早期參與始動(dòng)過敏性氣道炎癥。2.嗜堿性粒細(xì)胞在體內(nèi)外誘導(dǎo)性表達(dá)OX40L。3.OX40-OX40L共刺激通路介導(dǎo)嗜堿性粒細(xì)胞誘導(dǎo)Th2細(xì)胞分化。4.在OVA誘導(dǎo)的過敏性氣道炎癥中,OX40-OX40L共刺激通路介導(dǎo)嗜堿性粒細(xì)胞誘發(fā)Th2免疫應(yīng)答,導(dǎo)致過敏性氣道炎癥。
[Abstract]:Background bronchial asthma is a chronic allergic airway inflammation based on Th2 immune response. In recent years, it has been found that basophil can induce Th2 immune response in different disease models, but its specific mechanism is not clear. OX40-OX40L costimulatory pathway plays an important role in Th cell differentiation and asthma. Objective to elucidate and clarify the role of eosinophil in allergic airway inflammation in vitro and in vivo, and to further explore the signaling molecular mechanism of allergic airway inflammation induced by basophil initiating Th2 immune reaction. Method 1. The asthma airway inflammation model was established in mice immunized with OVA. The basophil in mediastinal lymph nodesMLNs was observed in the mediastinal lymph in the early stage of asthmatic inflammation in mice. Dendritic cells (Th2) and the changes of basophilic granulocyte surface molecular expression. 2. An in vitro culture system of IL-3 induced bone marrow cells to differentiate into basophil was established, and basophil was separated and identified by flow cytometry. On this basis, the expression characteristics of bone marrow-derived basophils BM-Baso OX40 and OX40L in medullary basophilic granulocytes were observed. The differentiation system of Th2 cells induced by basophilic granulocytes in vitro was established. On this basis, OX40L closed antibody (anti-mouse CD252 antibody) or OX40- / -r-mouse na?ve T cell were used. To observe the effect of blocking OX40-OX40L costimulatory pathway on the differentiation of Th2 cells induced by basophil. 4. 4. The asthmatic model of C57BL/6 mice was established by sensitizing with OVA, and the airway histopathological changes were observed by injecting OX40L blocking antibody (anti-mouse CD252 antibody) into caudal vein at sensitizing stage. The changes of eosinophils and Th2 type cytokines IL-4IL-5 and IL-13 in serum OVA specific Ig E(Ovalbumin-special immunoglobulin and bronchoalveolar lavage fluid (BALF) and Th2 type cytokines (IL-4, IL-5 and IL-13) in bronchoalveolar lavage fluid (bronchoalveolar lavage fluid, bronchoalveolar lavage fluid) and Th2 type cytokines (IL-4, IL-4, IL-5 and IL-13) were observed. To establish a mouse asthma model induced by adoptive reinjection of MLN basophils in vitro and observe the changes of MLN Th2 cell ratio and airway histopathology after blocking OX40-OX40L co-stimulation pathway in mice. The changes of eosinophil count and Th2 type cytokine IL-4 IL-5 and IL-13 in serum OVA-s Ig euclif. Result 1. In the early stage of asthma inflammation, the number of basophilic granulocytes in MLN increased significantly, but the number of DCs did not change, and the peak time of the number of basophil was earlier than that of Th2 cells. At the same time, the change of OX40L signal molecules on basophil surface was the most significant. 2. 2. BM-Bas was induced by IL-3 in vitro and stimulated by DNP-OVA and anti DNP-Ig E complex. Blocking OX40-OX40L costimulatory pathway in vitro reduced the percentage of differentiation of Th2 cells induced by basophil. 4. 4. The blocking of OX40-OX40L costimulatory pathway by CD252 antibody in sensitized mice decreased serum OVA-s Ig E, decreased the number of eosinophils in BALF, decreased the levels of IL-4 IL-5 and IL-13 in BALF, and alleviated allergic airway inflammation of lung tissue. MLN basophilic granulocytes initiated Th2 immune response to induce asthma inflammation in mice in vitro, while the percentage of Th2 cells in MLN of OX40 + -r-receptor mice and WT C57BL/6 receptor mice treated with OX40L was decreased. Allergic airway inflammation in the lungs is alleviated. Conclusion 1. Basophilic granulocytes are involved in allergic airway inflammation. 2. 2. In vitro and in vivo expression of OX40L.3.OX40-OX40L costimulatory pathway mediated differentiation of Th2 cells induced by basophil. In allergic airway inflammation induced by OVA, OX40-OX40L costimulatory pathway mediates Th2 immune response induced by basophil, leading to allergic airway inflammation.
【學(xué)位授予單位】：上海交通大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2015
【分類號(hào)】：R725.6

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 李鵬;胡明道;;共刺激通路與同種異體器官移植免疫耐受[J];醫(yī)學(xué)研究雜志;2011年08期

2 王穎,鄧宇斌;關(guān)于阻斷共刺激通路誘導(dǎo)移植免疫耐受的實(shí)驗(yàn)動(dòng)物研究進(jìn)展[J];免疫學(xué)雜志;2004年S1期

3 蔡勇,周佩軍,張善中,譚建明,唐孝達(dá);阻斷共刺激通路誘導(dǎo)產(chǎn)生免疫無能狀態(tài)[J];中華器官移植雜志;2003年05期

4 吳劍卿,孫蕓;ICOS-ICOSL共刺激通路及其功能的研究進(jìn)展[J];國(guó)外醫(yī)學(xué)(生理、病理科學(xué)與臨床分冊(cè));2003年05期

5 顧曉;CD40共刺激通路與移植排斥反應(yīng)[J];國(guó)外醫(yī)學(xué).泌尿系統(tǒng)分冊(cè);1999年06期

6 楊尚琪,唐孝達(dá);針對(duì)T細(xì)胞活化共刺激通路的抗移植排斥研究進(jìn)展[J];國(guó)外醫(yī)學(xué).泌尿系統(tǒng)分冊(cè);2000年S1期

7 肖毅,陳力真;CD_(28)/CTLA_4-B_7 T細(xì)胞共刺激通路與移植免疫[J];國(guó)外醫(yī)學(xué).外科學(xué)分冊(cè);1997年01期

8 趙高平;B7-CD28/CTLA4共刺激通路與胰島移植[J];中國(guó)普外基礎(chǔ)與臨床雜志;2002年06期

9 蔡勇,周佩軍,唐孝達(dá);阻斷共刺激通路誘導(dǎo)產(chǎn)生的無能細(xì)胞的抗原特異性免疫調(diào)節(jié)作用[J];中國(guó)免疫學(xué)雜志;2004年04期

10 陳棟;李明;尹注增;劉斌;陳剛;張偉杰;陳實(shí);;CD3/Crry共刺激通路對(duì)小鼠CD4~+ T細(xì)胞的免疫調(diào)控[J];實(shí)用醫(yī)學(xué)雜志;2010年02期

相關(guān)會(huì)議論文 前3條

1 孫運(yùn)鵬;吳歡歡;廖毅;單云峰;楊文軍;施紅旗;張啟瑜;;阻斷CD40/CD40L共刺激通路延長(zhǎng)大鼠移植肝臟存活時(shí)間[A];2012年浙江省外科學(xué)學(xué)術(shù)年會(huì)論文集[C];2012年

2 蔡勇;楊亦榮;夏鵬;鄭少玲;劉勇;吳存造;沈龍捷;孫賢斌;徐自強(qiáng);;阻斷CD154-CD40共刺激通路誘導(dǎo)產(chǎn)生IL-10依賴的免疫調(diào)節(jié)性T細(xì)胞[A];2005年浙江省器官移植學(xué)術(shù)會(huì)議論文匯編[C];2005年

3 楊佳薈;張軍;王建;蔡青;趙東寶;韓星海;沈茜;;ICOS共刺激通路對(duì)SLE患者T、B細(xì)胞免疫調(diào)控的體外研究[A];第十屆全軍檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2005年

相關(guān)博士學(xué)位論文 前7條

1 邸彩霞;OX40-OX40L共刺激通路介導(dǎo)嗜堿性粒細(xì)胞始動(dòng)過敏性氣道炎癥的研究[D];上海交通大學(xué);2015年

2 蔡勇;體外阻斷共刺激通路誘導(dǎo)產(chǎn)生的無能細(xì)胞的免疫調(diào)節(jié)作用[D];復(fù)旦大學(xué);2004年

3 鄭曉麗;LIGHT-HVEM共刺激通路在移植物抗宿主病中作用的研究[D];第二軍醫(yī)大學(xué);2008年

4 王煒;RNAi阻斷B7/CD28共刺激通路在小鼠心臟移植中的抗排斥反應(yīng)作用[D];天津醫(yī)科大學(xué);2005年

5 肖毅;CD28/CTLA4-B7 T細(xì)胞共刺激通路與移植免疫mAb CD28及其Fab片段免疫抑制作用機(jī)理的實(shí)驗(yàn)研究[D];中國(guó)協(xié)和醫(yī)科大學(xué);1997年

6 朱鵬;共刺激通路聯(lián)合阻斷及同種反應(yīng)性CD4~+記憶性T細(xì)胞對(duì)同種異體移植物存活影響及其機(jī)制研究[D];華中科技大學(xué);2008年

7 許雪青;AdvmICOSIg阻斷ICOS共刺激通路對(duì)MLD-STZ誘導(dǎo)的T1D的治療作用[D];第三軍醫(yī)大學(xué);2006年

相關(guān)碩士學(xué)位論文 前3條

1 邢敬龍;CD40 shRNA干擾CD40-CD40L在阻斷共刺激通路作用的實(shí)驗(yàn)研究[D];天津醫(yī)科大學(xué);2006年

2 秦偉;RNAi抑制小鼠樹突細(xì)胞共刺激通路的體外研究[D];天津醫(yī)科大學(xué);2009年

3 殷述剛;CTLA4-Ig聯(lián)合shRNA阻斷B7/CD28共刺激通路誘導(dǎo)小鼠T細(xì)胞免疫無能的研究[D];天津醫(yī)科大學(xué);2010年

，

本文編號(hào)：1951637